Operating Lease, Right-of-Use Asset of Editas Medicine, Inc. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Editas Medicine, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • Editas Medicine, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $17,583,000, a 51% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Editas Medicine, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $17,583,000 -$18,145,000 -51% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $19,011,000 -$17,940,000 -49% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $26,429,000 -$5,014,000 -16% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $32,554,000 -$1,126,000 -3.3% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $35,728,000 +$3,792,000 +12% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $36,951,000 +$2,140,000 +6.1% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $31,443,000 -$4,901,000 -13% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $33,680,000 -$9,968,000 -23% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q3 2023 $31,936,000 +$9,404,000 +42% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $34,811,000 +$14,145,000 +68% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $36,344,000 +$12,887,000 +55% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $43,648,000 +$17,475,000 +67% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $22,532,000 -$5,269,000 -19% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $20,666,000 -$9,648,000 -32% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $23,457,000 -$5,848,000 -20% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $26,173,000 +$1,045,000 +4.2% 31 Dec 2021 10-K 22 Feb 2023 2022 FY
Q3 2021 $27,801,000 +$1,403,000 +5.3% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $30,314,000 +$1,745,000 +6.1% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $29,305,000 +$2,283,000 +8.4% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $25,128,000 -$3,633,000 -13% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $26,398,000 +$8,717,000 +49% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $28,569,000 +$11,092,000 +63% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $27,022,000 +$8,542,000 +46% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $28,761,000 +$9,300,000 +48% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $17,681,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $17,477,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $18,480,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $19,461,000 01 Jan 2019 10-K 26 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.